Abstract
The objective of this study was to test a self-management model for self-management in people living with HIV and type 2 diabetes (PLWH + T2DM). We conducted a predictive, longitudinal study of data from a national research cohort of PLWH using lag analysis to test short- and long-term health outcomes for PLWH + T2DM. We used a dataset from the Center for AIDS Research (CFAR) Network of Integrated Clinic Systems (CNICS), a nation-wide research network of 8 clinics that serves PLWH. Patient-reported outcomes, collected at clinic visit, included depression, adherence, CD4 cell count, and health-related quality of life (HRQoL). We computed summary statistics to describe the sample. Using lag analysis, we then modeled the three variables of adherence, CD4 count, and HRQoL as a function of their predecessors in our conceptual model. In the final model, an increase of in medication adherence corresponded to a small increase in HRQoL. An increase in CD4 count corresponded to a small increase in HRQoL. An increase in lagged depression was associated with a small decrease in HRQoL. The model was not sufficient to predict short- or long-term outcomes in PLWH + T2DM. Although depression had a moderate impact, the final model was not clinically significant. For people with a dual diagnosis of HIV and T2DM, variables other than those traditionally addressed in self-management interventions may be more important.
Resumen
El objetivo de este estudio era evaluar un modelo de autocontrol para el autocontrol en aquellas personas que viven con VIH y diabetes de tipo 2 (PLWH + T2DM). Llevamos a cabo un estudio predictivo y longitudinal de la información proveniente de un estudio nacional de una población base de PLWH usando un análisis de retraso para evaluar los resultados en la salud a corto y largo plazo para PLWH + T2DM. Utilizamos un conjunto de datos del Center for AIDS Research [Instituto para la Investigación del SIDA] (CFAR) Network of Integrated Clinic Systems [Red de Sistemas de Clínicas Integradas] (CNICS), una red de investigación nacional que cuenta con ocho clínicas al servicio de PLWH. Los resultados que los pacientes reportaron, recolectados en una visita médica, incluyen depresión, adherencia, conteo de células CD4 y la calidad de vida relacionado con la salud (HRQoL). Calculamos el resumen estadístico para describir la muestra. Utilizando análisis de retraso, modelamos luego las tres variables de adherencia, conteo de células CD4 y el HRQoL como función de su antecesor en nuestro modelo conceptual. En el modelo final, un aumento en la adherencia al medicamento correspondió a un aumento en el HRQoL. Un aumento en el conteo de células CD4 correspondió a un aumento en el HRQoL. Se asoció un aumento de depresión retardada con una disminución en el HRQoL. El modelo no fue suficiente como para predecir resultados a corto o largo plazo en PLWH + T2DM. A pesar de que la depresión tenía un impacto moderado, el modelo final no fue clínicamente significativo. Para aquellas personas con un diagnóstico doble de VIH y T2DM, otras variables, además de las que se abordan tradicionalmente en las intervenciones de autocontrol, podrían ser más importantes.
Similar content being viewed by others
Data Availability
Data is part of the Center for AIDS Research Network of Integrated Clinical system.
Code Availability
N/A
References
Linley, L., et al. 2018 Estimated HIV incidence and prevalence in the United States 2010–2015
Hernandez-Romieu AC, et al. Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010. BMJ Open Diabetes Res Care. 2017;5(1):e000304.
Zuniga J, Nguyen ML, Holstad M. Predictors of dual control of HIV and diabetes. AIDS Care. 2016;28(9):1124–7.
Vance DE, et al. Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care. 2011;22(1):17–25.
Paik IJ, Kotler DP. The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection. Best Pract Res Clin Endocrinol Metab. 2011;25(3):469–78.
Kalra S, et al. Understanding diabetes in patients with HIV/AIDS. Diabetol Metab Syndr. 2011;3(1):2.
Brown TT, et al. Association between systemic inflammation and incident diabetes mellitus in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care. 2010;33(10):2244–9.
Butt AA, et al. HIV infection and the risk of diabetes mellitus. AIDS (London, England). 2009;23(10):1227.
Harding JL, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.
Sudore RL, et al. Symptom burden of adults with type 2 diabetes across the disease course: diabetes & aging study. J Gen Intern Med. 2012;27(12):1674–81.
Haas L, et al. National standards for diabetes self-management education and support. Diabetes Educ. 2012;38(5):619–29.
Medapalli R, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. J Acquir Immune Defic Syndr. 1999;60(4):e393.
Dufouil C, et al. Diabetes and cognitive decline in a French cohort of patients infected with HIV-1. Neurology. 2015;85(12):1065–73.
Park, J., J. Zuniga, and A. Garcia 2019 Diabetes negatively impacts the 10-year survival rates of persons living with HIV (vol 30, pg 991, 2019). INTERNATIONAL JOURNAL OF STD & AIDS
Webel AR, et al. Measuring HIV self-management in women living with HIV/AIDS: a psychometric evaluation study of the HIV self-management scale. J Acquir Immune Defic Syndr. 1999;60(3):e72.
Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1–7.
Nachega JB, et al. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;58(9):1297–307.
Davies MJ, et al. Management of hyperglycaemia in type 2 diabetes. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetologia. 2018;61(12):2461–98.
Powers MA, et al. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American diabetes Association, the American association of diabetes educators, and the academy of nutrition and dietetics. Diabetes Educ. 2017;43(1):40–53.
Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99(6):926–43.
Group, W. 1998 Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological medicine 28(3): p. 551-558
Degroote S, Vogelaers D, Vandijck DM. What determines health-related quality of life among people living with HIV: an updated review of the literature. Archives of Public Health. 2014;72(1):40.
Jia H, et al. Health-related quality of life among men with HIV infection: effects of social support, coping, and depression. AIDS Patient Care STDS. 2004;18(10):594–603.
Jia H, et al. A further investigation of health-related quality of life over time among men with HIV infection in the HAART era. Qual Life Res. 2007;16(6):961–8.
Chen, H.-Y., D.J. Baumgardner, and J.P. Rice 2011 Peer reviewed: Health-related quality of life among adults with multiple chronic conditions in the united states, behavioral risk factor surveillance system, 2007. Preventing chronic disease 8(1)
Imayama I, et al. Determinants of quality of life in adults with type 1 and type 2 diabetes. Health Qual Life Outcomes. 2011;9(1):115.
Pruchno RA, Wilson-Genderson M, Heid AR. Multiple chronic condition combinations and depression in community-dwelling older adults. J Gerontol Series A: Biomed Sci Med Sci. 2016;71(7):910–5.
Das R, et al. Prevalence of depression in patients with type II diabetes mellitus and its impact on quality of life. Indian J Psychol Med. 2013;35(3):284.
Ronel J, et al. Anxiety, depression, and health-related quality of life in aging people living with HIV compared to diabetes patients and patients with minor health conditions: a longitudinal study. Psychol Health Med. 2018;23(7):823–30.
Gonzalez JS, et al. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquired Immune Defic Syndr. 2011;58(2):181–7.
Musselman DL, et al. Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes. J Psychiatr Res. 2014;52:21–7.
Brown SA, et al. Biobehavioral determinants of glycemic control in type 2 diabetes: a systematic review and meta-analysis. Patient Educ Couns. 2016;99(10):1558–67.
Jonkman NH, et al. Identifying components of self-management interventions that improve health-related quality of life in chronically ill patients: Systematic review and meta-regression analysis. Patient Educ Couns. 2016;99(7):1087–98.
Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34(7):645–9.
Oldenburg CE, Perez-Brumer AG, Reisner SL. Poverty matters: contextualizing the syndemic condition of psychological factors and newly diagnosed HIV infection in the United States. AIDS. 2014;28(18):2763–9.
Weaver LJ, Mendenhall E. Applying syndemics and chronicity: interpretations from studies of poverty, depression, and diabetes. Med Anthropol. 2014;33(2):92–108.
Mendenhall, E., et al., Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. Lancet, 2017. 389 North American Edition(10072): p. 951–963.
Byg B, et al. The utility of a syndemic framework in understanding chronic disease management among HIV-infected and type 2 diabetic men who have sex with men. J Community Health. 2016;41(6):1204–11.
Angeler DG, Viedma O, Moreno J. Statistical performance and information content of time lag analysis and redundancy analysis in time series modeling. Ecology. 2009;90(11):3245–57.
Kroenke K, et al. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–59.
Zuñiga JA, et al. Differences in health-related quality of life predictors in people living with HIV with and without diabetes. J Assoc Nurses AIDS Care. 2020;31(5):544–52.
Chesney MA, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000;12(3):255–66.
Spitzer RL, et al. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737–44.
Lin M, Lucas HC Jr, Shmueli G. Research commentary—too big to fail: large samples and the p-value problem. Inf Syst Res. 2013;24(4):906–17.
Sullivan GM, Feinn R. Using effect size—or why the P value is not enough. J Grad Med Educ. 2012;4(3):279–82.
Center for AIDS Research Network of Integrated Clinical Systems. Cohort Demographics. 2020; Available from: https://cpb-us-w2.wpmucdn.com/sites.uab.edu/dist/0/119/files/2020/05/2020-CNICS-Cohort-Demo.png.
Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–37.
Bock P, et al. Attrition when providing antiretroviral treatment at CD4 counts >500cells/muL at three government clinics included in the HPTN 071 (PopART) trial in South Africa. PLoS One. 2018;13(4):e0195127.
Wang H, et al. Consistent ART adherence is associated with improved quality of Life, CD4 counts, and reduced hospital costs in central China. AIDS Res Hum Retroviruses. 2009;25(8):757–63.
Sweeney SM, Vanable PA. The association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature. AIDS Behav. 2016;20(1):29–50.
Bacon KL, et al. Perceived racism and incident diabetes in the black women’s health study. Diabetologia. 2017;60(11):2221–5.
Schabert J, et al. Social stigma in diabetes. Patient-Patient-Cent Outcomes Res. 2013;6(1):1–10.
Gaston GB, Alleyne-Green B. The impact of African Americans’ beliefs about HIV medical care on treatment adherence: a systematic review and recommendations for interventions. AIDS Behav. 2013;17(1):31–40.
Acknowledgements
Heidi Crane, PhD, Chris Mathews, Ken Mayer for their assistance with the CNICS research cohort
Funding
National Institutes of Health, National Institute of Nursing Research (Grant No. R15NR017579). CNICS is an NIH funded program (Grant No. R24 AI067039) made possible by the National Institute of Allergy and Infectious Diseases (NIAID). The CFAR sites involved in CNICS include the University of Alabama at Birmingham (Grant No. P30 AI027767), University of Washington (Grant No. P30 AI027757), University of California San Diego (Grant No. P30 AI036214), University of California San Francisco (Grant No. P30 AI027763), Case Western Reserve University (Grant No. P30 AI036219), Johns Hopkins University (Grant No. P30 AI094189, Grant No. U01 DA036935), Fenway Health/Harvard (Grant No. P30 AI060354), and the University of North Carolina at Chapel Hill (Grant No. P30 AI50410).
Author information
Authors and Affiliations
Contributions
All authors had a significant part of the manuscript in writing, reviewing it, and revising its intellectual and technical content.
Corresponding author
Ethics declarations
Ethical Approval
University IRB deemed the research exempt and not human subjects because it was an de-identified data set.
Consent to Participate
N/A
Consent for Publication
N/A
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zuñiga, J.A., Sales, A., Jang, D.E. et al. Self-Management Model fails to Predict Quality of Life for People Living with Dual Diagnosis of HIV and Diabetes. AIDS Behav 26, 488–495 (2022). https://doi.org/10.1007/s10461-021-03405-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-021-03405-7